PDCD1 and Thrombocytopenia: AEs such as alopecia, asthenia, appetite or weight loss, nausea, mild transaminase elevation, thrombocytopenia, and rash occurred more frequently in the NACRT plus PD-1 inhibition group compared to the NACRT alone group.